OUR PRODUCTS
INFLORESCENCES OF MEDICINAL CANNABIS
ACTIVE INGREDIENTS
FINISHED PRODUCTS
INFLORESCENCES OF
MEDICINAL CANNABIS
AVATARA I
Dried cannabis inflorescences with a dominant THC chemotype.
Genetics: Sativa/Indica hybrid (sativa dominant 70/30%)
THC range: 18 – 22%
CBD range: <1%
Scale of effects: Sedative/Relaxing = 4 / Physical = 2 / Energizing = 9 / Mental = 8
Quality: GMP - GACP - ANMAT CE-2025-41535414-APN-INAME#ANMAT and EMA registration as a pharmaceutical supplier of medicinal cannabis
ORG 100052556.
AVATARA II
Dried cannabis inflorescences with a dominant THC chemotype.
Genetics: Indica/Sativa hybrid (indica dominant 60/40%)
THC range: 17 – 23%
CBD range: <1%
Effects scale: Sedative/Relaxing = 7 / Physical = 4 / Energizing = 5 / Mental = 7
Quality: GMP - GACP - ANMAT CE-2025-41535414-APN-INAME#ANMAT and EMA registration as a pharmaceutical supplier of medicinal cannabis
ORG 100052556.
BBS I
Dried cannabis inflorescences with a dominant THC chemotype.
Genetics: Indica/Sativa hybrid (Indica dominant 70/30%)
THC range: 15 – 21%
CBD range: <1%
Effects scale: Sedative/Relaxing = 6 / Physical = 8 / Energizing = 6 / Mental = 7
Quality: GMP - GACP - ANMAT CE-2025-41535414-APN-INAME#ANMAT and EMA registration as a pharmaceutical supplier of medicinal cannabis
ORG 100052556.
BBS II
Dried cannabis inflorescences with a dominant THC chemotype.
Genetics: Indica/Sativa hybrid (balanced 50/50%)
THC range: 18 – 25%
CBD range: <1%
Scale of effects: Sedative/Relaxing = 5 / Physical = 3 / Energizing = 7 / Mental = 8
Quality: GMP - GACP - ANMAT CE-2025-41535414-APN-INAME#ANMAT and EMA registration as a pharmaceutical supplier of medicinal cannabis
ORG 100052556.
BBS III
Dried cannabis inflorescences with a dominant THC chemotype.
Genetics: Indica/Sativa hybrid (balanced 50/50%)
THC range: 19 – 23%
CBD range: <1%
Scale of effects: Sedative/Relaxing = 4 / Physical = 2 / Energizing = 8 / Mental = 9
Quality: GMP - GACP - ANMAT CE-2025-41535414-APN-INAME#ANMAT and EMA registration as a pharmaceutical supplier of medicinal cannabis
ORG 100052556.
ACTIVE INGREDIENTS OF
MEDICINAL CANNABIS
Full spectrum cannabis extracts
-
Crude extract containing all the active components of the plant including cannabinoids and terpenes.
Broad spectrum distillates
Purified and concentrated extract of CBD or THC, with low content of minor cannabinoids, terpenes, flavonoids and plant metabolites.
CBD isolate
Pure cannabidiol concentrate. CBD > 99%
FINISHED PRODUCTS
OF MEDICINAL CANNABIS
We develop pharmaceutical formulations using our own active ingredients—not imported ones—which are purified in a pharmaceutical manufacturing facility licensed by ANMAT, using state-of-the-art pharmaceutical technology.
-
No preservatives
-
No alcohol
-
No sweeteners
-
Each batch is tested and released in accordance with pharmacopoeia standards
-
Backed by our own clinical studies to ensure efficacy
Our products are backed by ongoing and completed clinical studies conducted in Argentina with local patients, and our results are scientifically proven. This sets us apart from other products that rely solely on equivalencies with foreign products.
We offer two distinct lines of pharmaceutical formulations:
CANNABIDIOL (CBD) ISOLATES LINE
This product line uses an extract of medical cannabis flowers as its active pharmaceutical ingredient. The extract is purified using pharmaceutical-grade technology, which isolates the CBD molecule to 100% purity and ensures that no other cannabinoids, terpenes, or flavonoids are detectable.
Featured Product:
CBD 10 (10 ml) – registered with ANMAT as a medicinal cannabis plant-based product. Indications: refractory epilepsy (supported by our own clinical study) and other conditions as prescribed by a physician.
CANNAVA
CBD 10
Therapeutic-medicinal product made from CBD isolates.
Free of heavy metals, pesticides and contaminants.
Gluten-free.
Potency: 10% CBD (100mg/ml).
Pharmaceutical form: oral solution.
Active ingredient: cannabidiol.
Excipient: pharmaceutical grade sesame oil, lemon flavoring.
Quality: GMP - GACP - ANMAT CE-2025-41535414-APN-INAME#ANMAT and EMA registration as a pharmaceutical supplier of medicinal cannabis
ORG 100052556.
Packaging: in amber PET dropper bottle with nitrogen injection.
Presentations: 10 ml
CANNABIS EXTRACT LINE
Formulations with extracts/distillations that integrate cannabinoids, terpenes,
and other compounds natural components of cannabis.
These products are currently under clinical study for chronic pain, with preliminary results showing a reduction in pain of 30%, 50%, and up to 100%.
Cannava sets a new standard in medicinal cannabis:
own clinical evidence, local production and real pharmaceutical quality.